TRIM33 and nasopharyngeal carcinoma: Finally, regarding oropharyngeal and nasopharyngeal carcinomas there is evidence from Asian groups that is linked to CAM anti-TIF1γ(+).33 In our group, there was only one case and therefore conclusions are not safe.